Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture

Abstract

16,23-D(3) and 1 alpha-OH-D(2) are effective in tumor reduction in two mouse models of RB with low toxicity. These results warrant initiating phase 1 and phase 2 clinical studies in children.